਀㰀栀琀洀氀㸀 ਀㰀氀椀渀欀 爀攀氀㴀∀猀琀礀氀攀猀栀攀攀琀∀ 琀礀瀀攀㴀∀琀攀砀琀⼀挀猀猀∀ 栀爀攀昀㴀∀猀琀礀氀攀⸀挀猀猀∀⼀㸀 ਀㰀戀漀搀礀㸀

Centre de Référence des Rhumatismes Inflammatoires et Maladies Autoimmunes Systémiques Rares de l’Enfant (RAISE) / 2017

66

Katsicas

MM,

Russo

R

a.

G.

Use of infliximab in patients with

systemic

juvenile

idiopathic

arthritis refractory to etanercept.

Clin

Exp

Rheumatol.

Aug;23(4):545–8.

2005

Kimura

Y,

Pinho

P,

Walco

G,

Higgins G, Hummell D, Szer I, et

al.

Etanercept

treatment

in

patients with refractory systemic

onset
arthritis.

juvenile

rheumatoid

J

Rheumatol.

May;32(5):935–42.

2005

Lehman
Sundel

TJA,

RP,

Huttenlocher

Schechter

Oliveira

SJ,

SK,
KB.

A,

Onel

Thalidomide for severe systemic

onset

juvenile

rheumatoid

arthritis:

A

multicenter

study.

J

Pediatr.

2004

Dec;145(6):856–

7.

Lequerré T, Quartier P, Rosellini
D, Alaoui F, De Bandt M, Mejjad
O,

et

al.

Interleukin-1

receptor

antagonist

(anakinra)

treatment

in

patients

with

systemic-onset

juvenile
adult
preliminary

idiopathic

arthritis

or

disease:

onset

Still

experience

in

France.

Ann

Rheum

Dis.

2008

Mar;67(3):302–8.

Lovell DJ, Giannini EH, Reiff A,
Jones

OY,

Schneider

R,

Olson

JC, et al. Long-term efficacy and
safety

of

etanercept

in

children

with polyarticular-course juvenile

rheumatoid

arthritis:

interim

ongoing

results

from

multicenter,

an

open-label,

trial.

extended-treatment

Arthritis

Rheum.

Jan;48(1):218–26.

2003

Lovell

DJ,

Reiff

A,

Ilowite

NT,

Wallace CA, Chon Y, Lin S-L, et

al.

Safety

and

efficacy

of

up

to

eight

years

of

continuous

etanercept therapy in patients

with

juvenile

rheumatoid

arthritis.

Arthritis

Rheum.

2008 May;58(5):1496–504.

Lovell

DJ,

Ruperto

N,

Goodman S, Reiff A, Jung L,

Jarosova

K,

et

al.

Adalimumab

with

or

without

methotrexate

in

rheumatoid arthritis.

juvenile

N Engl J

Aug

Med.

2008

21;359(8):810–20.

Niehues

T,

Lankisch

P.

the

in

Recommendations

for

methotrexate

use

of

juvenile

idiopathic

arthritis.

Paediatr
2006;8(6):347–56.

Drugs.

Ortiz-Alvarez

O,

Morishita

K,

Avery G, Green J, Petty RE,
Tucker

LB,

et

al.

Guidelines

for

blood

test

monitoring

of

methotrexate

toxicity

in

juvenile

idiopathic

arthritis.

J

Rheumatol.
Dec;31(12):2501

2004

–6.

Pascual

V,

Allantaz

F,

Arce

E,

Punaro

M,

Banchereau

J.

Role

of

interleukin-1

(IL-1)

in

the pathogenesis of systemic

onset

juvenile

idiopathic

arthritis and clinical response
to IL-1 blockade. J Exp Med.
2005 May 2;201(9):1479–86.

Pham

T,

Claudepierre

P,

Deprez

X.

Traitements

anti-

TNF

alpha

et

suivi

de

la

tolérance.

Revue

2008 ; 75 (5).

Rhum

Pham

T,

Constantin

Claudepierre

P,

en

A.

Prise

਀㰀⼀栀琀洀氀㸀